R13
Sign inGet started
🇫🇷

AMYLYX PHARMACEUTICALS FRANCE SAS

SIC72.11ZID918501131VATFR58918501131

📍 5 RUE DE L'ARC DE TRIOMPHE 75017 PARIS

Financial data

Sign in to unlock
Revenue
•••••
EBITDA
•••••
Net result
•••••
Fiscal year
2024
Revenue, EBIT, net result and balance-sheet figures are as reported to the public register. EBITDA marked Estimated is derived from revenue × the sector-average margin (used where EBITDA is not publicly filed, e.g. France) and is not an audited figure.

Other companies in this sector

Same country and activity, ranked by how much data we hold. The list is free — open any company to see its own page.

SYNGENTA FRANCE SAfinancials→INSTITUT SERVIER D'INNOVATION THERAPEUTIQUEfinancials→IPSEN INNOVATIONfinancials→EUROLYSINEfinancials→METABOLIC EXPLORERfinancials→ORPHALAN (GMPO)financials→

Direction

2
Sign in to unlock
  • •••••••••••
    •••••
  • •••••••••••
    •••••
2 board members · unlocks alongside financials

Recent events (BODACC)

63 more behind unlock
DateTypeLabelTribunal
2025-••-••RADIATION•••••••••••• ••••••Tribunal de •••••••
2025-••-••MODIFICATION•••••••••••• ••••••Tribunal de •••••••
2025-••-••DPC•••••••••••• ••••••Tribunal de •••••••

Data sourced from official commercial registries. Last updated when this company filed its accounts.